Reporter April 10 2020

VUMC team aids development of potential antiviral drug for COVID-19

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

Vanderbilt team develops COVID-19 predictive model for Tennessee

A team including health economists, epidemiologists and a biostatistician at Vanderbilt University Medical Center and Vanderbilt University are amassing and processing data to develop a complex predictive model of the spread of COVID-19 within Tennessee, with region-specific projections, as well as a model of projected resource use during response to the pandemic.

Mias Pretorius, MBChB, MSCI, chief of Cardiothoracic Anesthesiology at Vanderbilt University Medical Center (VUMC), models one of the face shields he and his family assembled to provide back-up personal protective equipment (PPE).

Physicians, engineering students, families and friends construct DIY face shields

As the number of COVID-19 infections continues to grow, Nashville resident Kobie Pretorius was searching for some way to provide meaningful help to others. And she realized her apprehension was spiking each morning as her husband went out the door for work.

1 2